[Federal Register Volume 70, Number 35 (Wednesday, February 23, 2005)]
[Notices]
[Pages 8868-8872]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-3427]


=======================================================================
-----------------------------------------------------------------------

UNITED STATES SENTENCING COMMISSION


Sentencing Guidelines for United States Courts

AGENCY: United States Sentencing Commission.

ACTION: Notice of proposed amendments to sentencing guidelines, policy 
statements, and commentary. Request for public comment, including 
public comment regarding retroactive application of any of the proposed 
amendments. Notice of public hearing.

-----------------------------------------------------------------------

SUMMARY: Pursuant to section 994(a), (o), and (p) of title 28, United 
States Code, the United States Sentencing Commission is considering 
promulgating certain amendments to the sentencing guidelines, policy 
statements, and commentary. This notice sets forth the proposed 
amendments and, for each proposed amendment, a synopsis of the issues 
addressed by that amendment. This notice also provides multiple issues 
for comment, some of which are contained within proposed amendments.
    The specific proposed amendments and issues for comment in this 
notice are as follows: (1) A proposed amendment to implement sections 2 
and 5 of the Identity Theft Penalty Enhancement Act, Public Law 108-275 
and a related issue for comment; (2) a proposed amendment to implement 
the Antitrust Criminal Penalty Enhancement and Reform Act of 2004, 
Public Law 108-237 and related issues for comment; (3) an issue for 
comment on how to implement the directive to the Commission in section 
3 of the Anabolic Steroid Control Act of 2004, Public Law 108-358; and 
(4) proposed amendments that make various

[[Page 8869]]

technical and conforming amendments to the guidelines.

DATES: (1) Proposed Amendments and Issues for Comment.--Written public 
comment regarding the proposed amendments and issues for comment set 
forth in this notice should be received by the Commission not later 
than March 25, 2005.
    (2) Public Hearing.--The Commission has scheduled a public hearing 
on its proposed amendments for April 12, 2005, at the Thurgood Marshall 
Federal Judiciary Building, One Columbus Circle, NE., Washington, DC 
20002-8002. A person who desires to testify at the public hearing 
should notify Michael Courlander, Public Affairs Officer, at (202) 502-
4590, not later than March 10, 2005. Written testimony for the public 
hearing must be received by the Commission not later than March 28, 
2005. Timely submission of written testimony is a requirement for 
testifying at the public hearing. The Commission requests that, to the 
extent practicable, commentators submit an electronic version of the 
comment and of the testimony for the public hearing. The Commission 
also reserves the right to select persons to testify at any of the 
hearings and to structure the hearings as the Commission considers 
appropriate and the schedule permits. Further information regarding the 
public hearing, including the time of the hearing, will be provided by 
the Commission on its Web site at http://www.ussc.gov.

ADDRESSES: Public comment should be sent to: United States Sentencing 
Commission, One Columbus Circle, NE., Suite 2-500, Washington, DC 
20002-8002, Attention: Public Affairs.

FOR FURTHER INFORMATION CONTACT: Michael Courlander, Public Affairs 
Officer, telephone: (202) 502-4590.

SUPPLEMENTARY INFORMATION: The United States Sentencing Commission is 
an independent agency in the judicial branch of the United States 
Government. The Commission promulgates sentencing guidelines and policy 
statements for Federal courts pursuant to 28 U.S.C. 994(a). The 
Commission also periodically reviews and revises previously promulgated 
guidelines pursuant to 28 U.S.C. 994(o) and submits guideline 
amendments to the Congress not later than the first day of May of each 
year pursuant to 28 U.S.C. 994(p).
    The Commission seeks comment on the proposed amendments, issues for 
comment, and any other aspect of the sentencing guidelines, policy 
statements, and commentary.
    The proposed amendments in this notice are presented in one of two 
formats. First, some of the amendments are proposed as specific 
revisions to a guideline or commentary. Bracketed text within a 
proposed amendment indicates a heightened interest on the Commission's 
part on comment and suggestions regarding alternative policy choices; 
for example, a proposed enhancement of [2] levels indicates that the 
Commission is considering, and invites comment on, alternative policy 
choices regarding the appropriate level of enhancement. Similarly, 
bracketed text within a specific offense characteristic or application 
note means that the Commission specifically invites comment on whether 
the proposed provision is appropriate. Second, the Commission has 
highlighted certain issues for comment and invites suggestions on how 
the Commission should respond to those issues.
    The Commission also requests public comment regarding whether the 
Commission should specify for retroactive application to previously 
sentenced defendants any of the proposed amendments published in this 
notice. The Commission requests comment regarding which, if any, of the 
proposed amendments that may result in a lower guideline range should 
be made retroactive to previously sentenced defendants pursuant to 
Sec.  1B1.10 (Reduction in Term of Imprisonment as a Result of Amended 
Guideline Range).
    Additional information pertaining to the proposed amendments 
described in this notice may be accessed through the Commission's Web 
site at http://www.ussc.gov.

    Authority: 28 U.S.C. 994(a), (o), (p), (x); USSC Rules of 
Practice and Procedure, Rule 4.4.

Ricardo H. Hinojosa,
Chair.

    1. Proposed Amendment: Aggravated Identity Theft.
    Synopsis of Proposed Amendment: This proposed amendment implements 
sections 2 and 5 of the Identity Theft Penalty Enhancement Act, Public 
Law 108-275, 118 Stat. 831 (``the Act''), which creates two new 
criminal offenses and provides a specific directive to the Sentencing 
Commission regarding the upward adjustment at Sec.  3B1.3 (Abuse of 
Position of Trust/Special Skill). First, the Act creates a new offense 
at 18 U.S.C. 1028A(a)(1) that prohibits the unauthorized transfer, use, 
or possession of a means of identification of another person during, or 
in relation to, specific enumerated felonies. These felonies consist of 
various types of fraud, including false statements and documents in 
connection with immigration and citizenship laws, passports, visas, the 
Social Security Act, and the acquisition of firearms. A conviction 
under 18 U.S.C. 1028A(a)(1) carries a two-year mandatory sentence that 
must run consecutive to any other term of imprisonment, including the 
sentence for the underlying felony conviction. The new criminal offense 
at 18 U.S.C. 1028A(b)(1) prohibits the unauthorized transfer, use, or 
possession of a means of identification of another person during, or in 
relation to, specific felonies enumerated in 18 U.S.C. 2332b(g)(5)(B) 
(``federal crimes of terrorism''). Section 1028A(b)(1) provides a five-
year mandatory sentence that must run consecutive to any other term of 
imprisonment, including the sentence for the underlying felony 
conviction.
    In response to the creation of these new offenses, the proposed 
amendment creates a new guideline at Sec.  2B1.6 (Aggravated Identity 
Theft). The proposed guideline is patterned after Sec.  2K2.4 (Use of a 
Firearm, Armor-Piercing Ammunition, or Explosive During or in Relation 
to Certain Crimes). Because the new offenses carry a mandatory 
consecutive term of imprisonment, the proposed guideline, as does Sec.  
2K2.4, provides that the ``guideline sentence is the term of 
imprisonment required by statute''.
    Second, section 5 of the Act directs the Commission to amend Sec.  
3B1.3 (Abuse of Position of Trust or Use of Special Skill) to include a 
``defendant [who] exceeds or abuses the authority of his or her 
position in order to obtain unlawfully or use without authority any 
means of identification. * * *'' The Act also includes a general 
directive to the Commission to review and amend its guidelines and 
policy statements to ensure that the guideline offense levels and 
enhancements appropriately punish identity theft offenses involving an 
abuse of trust. In response to the directive, the proposed amendment 
amends Sec.  3B1.3 to ensure that an adjustment under this guideline 
applies to ``a defendant who uses his or her position in order to 
obtain unlawfully, or use without authority, any means of 
identification''. To avoid double-counting, the amendment proposes an 
application note that prohibits the application of any specific offense 
characteristic for the transfer, possession, or use of a means of 
identification when determining the sentence for the underlying offense 
in cases in which a sentence under the

[[Page 8870]]

new guideline is imposed in conjunction with a sentence for an 
underlying offense.
    Finally, the proposal simplifies the application of the enhancement 
at Sec.  2B1.1(b)(10), which currently covers offenses involving 
identity theft, access devices, and counterfeit devices, by changing it 
from an enhancement based on relevant conduct to an enhancement based 
on the offense of conviction. This is in response to comments from 
practitioners, since the enhancement's promulgation in 1998, that the 
enhancement in its current form is confusing and applied 
inconsistently.
    Proposed Amendment:
    Section 2B1.1(b)(10) is amended by striking ``offense involved 
(A)'' and all that follows through ``of, another means of 
identification,'' and inserting ``defendant was convicted of an offense 
under 18 U.S.C. 1028(a)(5), (a)(7), or Sec.  1029(a)(4),''.
    The Commentary to Sec.  2B1.1 captioned ``Application Notes'' is 
amended by striking Application Note 9 and inserting the following:
    ``9. Application of Subsection (b)(10).--Subsection (b)(10) 
provides a 2-level increase, and a minimum offense level of level 12, 
if the defendant was convicted of an offense under 18 U.S.C. 1028(a)(5) 
or (a)(7), or Sec.  1029(a)(4).''.
    Chapter Two, part B, subpart 1 is amended by adding at the end the 
following new guideline and accompanying commentary:

``Sec.  2B1.6. Aggravated Identity Theft

    (a) If the defendant was convicted of violating 18 U.S.C. 1028A, 
the guideline sentence is the term of imprisonment required by statute. 
Chapters Three (Adjustments) and Four (Criminal History and Criminal 
Livelihood) shall not apply to that count of conviction.

Commentary

    Statutory Provision: 18 U.S.C. 1028A.

Application Note

    1. Inapplicability of Chapter Two Enhancement.--If a sentence under 
this guideline is imposed in conjunction with a sentence for an 
underlying offense, do not apply any specific offense characteristic 
for the transfer, possession, or use of a means of identification when 
determining the sentence for the underlying offense. A sentence under 
this guideline accounts for this factor for the underlying offense of 
conviction, including any such enhancement that would apply based on 
conduct for which the defendant is accountable under Sec.  1B1.3 
(Relevant Conduct). ``Means of identification'' has the meaning given 
that term in 18 U.S.C. 1028(d)(7).''.
    The Commentary to Sec.  3B1.3 captioned ``Application Notes'' is 
amended in Note 1 by inserting ``'Public or Private Trust'.--'' before 
``'Public or private trust'' refers to''; and by striking the second 
paragraph and inserting the following:
    ``Notwithstanding the preceding paragraph, an abuse of position of 
trust will apply to--
    (A) any employee of the U.S. Postal Service who engages in the 
theft or destruction of undelivered United States mail, due to the 
special nature of the United States mail; or
    (B) a defendant who uses his or her position in order to obtain 
unlawfully, or use without authority, any means of identification. 
``Means of identification'' has the meaning given that term in 18 
U.S.C. 1028(d)(7).''.
    The Commentary to Sec.  3B1.3 captioned ``Application Notes'' is 
amended by inserting at the end the following:
    5. ``Inapplicability of Adjustment.''Do not apply this adjustment 
if the defendant is convicted of 18 U.S.C. 1028A or the base offense 
level or specific offense characteristic in Chapter Two incorporates 
this factor.''.
    The Statutory Index (Appendix A) is amended by inserting after the 
line referenced to 18 U.S.C. 1028 the following new line:
    ``18 U.S.C. 1028A 2B1.6''.
    Issue for Comment: The Commission seeks comment regarding whether, 
and if so, how, the guidelines should be amended to address section 2 
of the Identify Theft Penalty Enhancement Act. For example, is policy 
guidance at Sec.  5G1.2 (Sentencing on Multiple Counts of Conviction) 
appropriate to prevent disproportionate sentences that can arise from 
multiple convictions of statutes carrying mandatory, consecutive 
penalties sentenced at the same time? Section 2 of the Identity Theft 
Penalty Enhancement Act amends 18 U.S.C. 1028A(b)(4) to provide that 
``a term of imprisonment imposed on a person for a violation of this 
section may, in the discretion of the court, run concurrently, in whole 
or in part, only with another term of imprisonment that is imposed by 
the court at the same time on that person for an additional violation 
of this section, provided that such discretion shall be exercised in 
accordance with any applicable guidelines and policy statements issued 
by the Sentencing Commission. * * *''
    2. Proposed Amendment: Antitrust Offenses.
    Synopsis of Proposed Amendment: This proposed amendment responds to 
the Antitrust Criminal Penalty Enhancement and Reform Act of 2004, 
Public Law 108-237, Title II (the ``Act''). Section 215 of the Act 
increases both the fines and statutory maximum terms of imprisonment 
for Sections 1, 2, and 3 of the Sherman Antitrust Act. The Act 
increased the maximum term of imprisonment from 3 years to 10 years, 
increased the maximum fine for corporations from $10,000,000 to 
$100,000,000, and increased the maximum fine for individuals from 
$350,000 to $1,000,000.
    Congress has expressed an expectation that the Commission modify 
the antitrust guideline, Sec.  2R1.1. The Act's Legislative History 
states:
    This section (Section 215 of the Act) will require the United 
States Sentencing Commission to revise the existing antitrust 
sentencing guidelines to increase terms of imprisonment for antitrust 
violations to reflect the new statutory maximum. No revision in the 
existing guidelines is called for with respect to fines, as the 
increases in the Sherman Act statutory maximum fines are intended to 
permit courts to impose fines for antitrust violations at current 
guideline levels without the need to engage in damages litigation 
during the criminal sentencing process. (Supplemental Legislative 
History, Cong. Rec. H 3658, June 2, 2004).
    The proposed amendment provides for a base offense level of level 
[12][14] at the guideline for antitrust offenses, Sec.  2R1.1 (Bid-
Rigging, Price-Fixing or Market-Allocation Agreements Among 
Competitors). This increase in the base offense level recognizes 
congressional concern that some of the offenses currently referenced to 
Sec.  2R1.1 do not receive punishment commensurate with their social 
impact. The increased base offense level also fosters greater 
proportionality between Sec.  2R1.1 offenses and fraud offenses 
sentenced pursuant to Sec.  2B1.1. Sentences for fraud offenses were 
made more severe due to various changes, notably an expansion of the 
number of additional offense levels at the ``loss table'' found at 
Sec.  2B1.1(b)(1), effective November 1, 2001.
    The proposed amendment also eliminates the 1-level increase for 
``bid-rigging'' cases at Sec.  2R1.1(b)(1). Commission data indicate 
that a significant majority of the cases historically sentenced under 
Sec.  2R1.1 are ``bid-rigging'' cases. Because of the demonstrated 
frequency of such offenses, this aggravating behavior has been 
incorporated into the new base offense level.
    Proposed Amendment:
    Section 2R1.1(a) is amended by striking ``10'' and inserting 
``[12][14]''.

[[Page 8871]]

    Section 2R1.1(b) is amended by striking subdivision (1); and by 
redesignating subdivision (2) as subdivision (1).
    The Commentary to Sec.  2R1.1 captioned ``Background'' is amended 
by striking the fifth paragraph.
    Issues for Comment:
    (1) The Commission seeks comment regarding whether the base offense 
level in Sec.  2R1.1 (Bid-Rigging, Price-Fixing or Market-Allocation 
Agreements Among Competitors) for antitrust offenses should be raised 
and, if so, to what extent.
    (2) The Commission requests comment regarding whether the volume of 
commerce table at subsection (b)(2) of Sec.  2R1.1 should (A) be 
amended to change the threshold values that trigger the offense level 
enhancements therein; (B) be modified to reduce the number of levels in 
the volume of commerce table; and/or (C) be modified to include an 
additional category or categories for offenses that affect volumes of 
commerce significantly in excess of $100,000,000.
    3. Issue for Comment: Anabolic Steroids.
    Issue for Comment: Section 3 of the Anabolic Steroid Control Act of 
2004, Public Law 108-358 (the ``Act''), directs the Commission to:
    ``(1) review the Federal sentencing guidelines with respect to 
offenses involving anabolic steroids;
    (2) consider amending the Federal sentencing guidelines to provide 
for increased penalties with respect to offenses involving anabolic 
steroids in a manner that reflects the seriousness of such offenses and 
the need to deter anabolic steroid trafficking and use; and
    (3) take such other action that the Commission considers necessary 
to carry out this section.''.
    Anabolic steroids are Schedule III controlled substances under 21 
U.S.C. 812. Under 21 U.S.C. 841(b)(1)(D), any person who knowingly or 
intentionally trafficks in, or possesses with intent to traffic in, a 
Schedule III controlled substance shall be sentenced to a term of 
imprisonment of not more than 5 years' imprisonment, or if the person 
committed the offense after a prior conviction for a felony drug 
offense has become final, not more than 10 years' imprisonment.
    A defendant who has a prior anabolic steroid offense is subject to 
the 10-year maximum term of imprisonment because section (2)(a)(2) of 
the Act amended 21 U.S.C. 802(44) to include anabolic steroid offenses 
within the meaning of ``felony drug offense(s)'' for purposes of the 
increased statutory maximum term of imprisonment.
    Currently Sec.  2D1.1 (Unlawful Manufacturing, Importing, 
Exporting, or Trafficking (Including Possession with Intent to Commit 
These Offenses); Attempt or Conspiracy) of the guidelines provides in 
the Drug Equivalency Tables that one unit of a Schedule III substance 
is the equivalent of one gram of marihuana for purposes of determining 
the defendant's base offense level under the Drug Quantity Table. For 
all Schedule III controlled substances except anabolic steroids, one 
unit equals one tablet or, if in liquid form, 0.5 milliliter. For 
anabolic steroids, one unit equals 50 tablets, or if in liquid form, 10 
cubic centiliters.
    The Commission requests comment regarding how the Commission should 
implement the directive in section 3 of the Act. Specifically, should 
the Commission amend the Drug Equivalency Tables and/or the Notes to 
the Drug Quantity Table in Sec.  2D1.1 to provide a heightened 
marihuana equivalency for anabolic steroids, and, if so, what should be 
the amended equivalency rate? For example, should the Commission treat 
anabolic steroids the same as other Schedule III controlled substances 
so that one tablet of anabolic steroids would equal one unit of 
Schedule III controlled substance and hence would equal one gram of 
marihuana?
    4. Proposed Amendment: Miscellaneous Amendments Package.
    Synopsis of Proposed Amendment: This proposed amendment makes 
changes to various sentencing guidelines as follows:
    (A) Makes technical amendments to several guidelines to conform to 
changes made in the public corruption guidelines in the 2004 amendment 
cycle (see Appendix C to the Guidelines Manual, Amendment 666). 
Specifically, the proposed amendment corrects title references to Sec.  
2C1.1 in Sec. Sec.  2B3.3(c)(1), 2C1.3(c)(1), and 2C1.8(c)(1) and 
strikes references to Sec.  2C1.7 in Sec. Sec.  3D1.2(d) and 8C2.1.
    (B) Clarifies Application Note 15 of the fraud guideline, Sec.  
2B1.1, to make clear that, in order for Sec.  2B1.1(c)(3) to apply, the 
conduct set forth in the count of conviction must establish a fraud or 
false statement-type offense. Currently, there is some confusion with 
regard to whether the cross reference is applicable if the defendant 
only lied about another offense.
    (C) Corrects the heading to Sec.  5C1.2 (Limitation on 
Applicability of Statutory Minimum Sentence in Certain Cases) in 
Application Note 2 of Sec.  5D1.2 (Terms of Supervised Release).
    (D) Corrects a typographical error in Sec.  2M6.1 (Unlawful 
Production, Development, Acquisition, Stockpiling, Alteration, Use, 
Transfer, or Possession of Nuclear Material, Weapons, or Facilities, 
Biological Agents, Toxins, or Delivery Systems, Chemical Weapons, or 
Other Weapons of Mass Destruction; Attempt or Conspiracy).
    (E) Conforms Sec.  2D1.11 (Unlawfully Distributing, Importing, 
Exporting or Possessing a Listed Chemical; Attempt or Conspiracy) to 
changes made to the drug guideline, Sec.  2D1.1, in the 2004 amendment 
cycle (see Appendix C to the Guideline Manual, amendment 667). 
Specifically, the proposed amendment amends the Chemical Quantity Table 
in Sec.  2D1.11(e) so that the amount of gamma-butyrolactone (GBL), at 
any particular offense level, is the amount that provides a 100 percent 
yield of gamma-hydroxybutyric acid (GHB).
    (F) Clarifies Application Note 5 in the drug guideline, Sec.  
2D1.1, regarding drug analogues. The current note suggests that a drug 
analogue is less potent than the drug for which it is an analogue; 
however, by statute, an analogue can only be the same or more potent.
    (G) Redesignates incorrect references in a number of Application 
Notes in the drug guideline, Sec.  2D1.1.
    Proposed Amendment:
    (A) Conforming Amendments Related to Public Corruption Amendments 
of 2004.
    Section 2B3.3(c)(1) is amended by inserting ``; Fraud Involving the 
Deprivation of the Intangible Right to Honest Services of Public 
Officials; Conspiracy to Defraud by Interference with Governmental 
Functions'' after ``; Extortion Under Color of Official Right''.
    Section 2C1.3(c)(1) is amended by inserting ``; Fraud Involving the 
Deprivation of the Intangible Right to Honest Services of Public 
Officials; Conspiracy to Defraud by Interference with Governmental 
Functions'' after ``; Extortion Under Color of Official Right''.
    Section 2C1.8(c)(1) is amended by inserting ``; Fraud Involving the 
Deprivation of the Intangible Right to Honest Services of Public 
Officials; Conspiracy to Defraud by Interference with Governmental 
Functions'' after ``; Extortion Under Color of Official Right''.
    Section 3D1.2(d) is amended by striking ``2C1.7,''.
    Section 8C2.1 is amended in subsection (a) by striking ``, 2C1.7''.
    (B) Commentary to Fraud Cross-Reference in Sec.  2B1.1
    The Commentary to Sec.  2B1.1 captioned ``Application Notes'' is 
amended in Note 15 in the first sentence by inserting ``involving 
fraudulent conduct that is'' before ``more aptly covered by another 
guideline.''; in the second sentence by inserting ``involves fraudulent 
conduct

[[Page 8872]]

that'' before ``is also covered by a more specific statute.''; and at 
the end by inserting the following:
    ``Subsection (c)(3) does not apply in a case in which a defendant 
is prosecuted under 18 U.S.C. 1001, or a similar statute, only for 
making false statements to a probation officer about other criminal 
conduct.''.
    (C) Commentary to Sec.  5D1.2
    The Commentary to Sec.  5D1.2 captioned ``Application Notes'' is 
amended in Note 2 by inserting ``Limitation on'' before ``Applicability 
of Statutory''.
    (D) Asterisked Note in Sec.  2M6.1(b)(1)(A)
    Section 2M6.1(b)(1) is amended in subdivision (A) by striking the 
asterisk after ``(a)(4)'' and inserting ``(A)''; and after subsection 
(b)(2) by striking ``*Note: The reference to `(a)(4)' should be to 
`(a)(4)(A)'.''.
    (E) Ratio of GBL to GHB in Sec.  2D1.11
    Section 2D1.11(e) is amended in subdivision (1) by striking ``2271 
L or more of Gamma-butyrolactone;'' and inserting ``1135.5 L or more of 
Gamma-butyrolactone;''; in subdivision (2) by striking ``At least 681.3 
L but less than 2271 L of Gamma-butyrolactone;'' and inserting ``At 
least 340.7 but less than 1135.5 L of Gamma-butyrolactone;''; in 
subdivision (3) by striking ``At least 227.1 L but less than 681.3 L of 
Gamma-butyrolactone;'' and inserting ``At least 113.6 L but less than 
340.7 L of Gamma-butyrolactone;''; in subdivision (4) by striking ``At 
least 159 L but less than 227.1 L of Gamma-butyrolactone;'' and 
inserting ``At least 79.5 L but less than 113.6 L of Gamma-
butyrolactone;''; in subdivision (5) by striking ``At least 90.8 L but 
less than 159 L of Gamma-butyrolactone;'' and inserting ``At least 45.4 
L but less than 79.5 L of Gamma-butyrolactone;''; in subdivision (6) by 
striking ``At least 22.7 L but less than 90.8 L of Gamma-
butyrolactone;'' and inserting ``At least 11.4 L but less than 45.4 L 
of Gamma-butyrolactone;''; in subdivision (7) by striking ``At least 
18.2 L but less than 22.7 L of Gamma-butyrolactone;'' and inserting 
``At least 9.1 L but less than 11.4 L of Gamma-butyrolactone;''; in 
subdivision (8) by striking ``At least 13.6 L but less than 18.2 L of 
Gamma-butyrolactone;'' and inserting ``At least 6.8 L but less than 9.1 
L of Gamma-butyrolactone;''; in subdivision (9) by striking ``At least 
9.1 L but less than 13.6 L of Gamma-butyrolactone;'' and inserting ``At 
least 4.5 L but less than 6.8 L of Gamma-butyrolactone;''; and in 
subdivision (10) by striking ``Less than 9.1 of Gamma-butyrolactone;'' 
and inserting ``Less than 4.5 of Gamma-butyrolactone;''.
    (F) Analogues of Controlled Substances
    The Commentary to Section 2D1.1 captioned ``Application Notes'' is 
amended in Note 5 by striking ``whether a greater quantity of the 
analogue is needed to produce a substantially similar effect on the 
central nervous system as'' and inserting ``whether the same quantity 
of analogue produces a greater effect on the central nervous system 
than''.
    (G) Redesignation of Incorrect References in Sec.  2D1.1
    The Commentary to Sec.  2D1.1 captioned ``Application Notes'' is 
amended in Note 19 by striking ``(b)(5)(A)'' and inserting 
``(b)(6)(A)''; in Note 20 by striking ``(b)(5)(B) or (C)'' and 
inserting ``(b)(6)(B) or (C)'', and by striking ``(b)(5)(C)'' and 
inserting ``(b)(6)(C)''; and in Note 21 by striking ``(b)(6)'' each 
place it appears and inserting ``(b)(7)''.
    The Commentary to Sec.  2D1.1 captioned ``Background'' is amended 
by striking ``(b)(5)(A)'' and inserting ``(b)(6)(A)'', and by striking 
``(b)(5)(B) and (C)'' and inserting ``(b)(6)(B) and (C)''.

[FR Doc. 05-3427 Filed 2-22-05; 8:45 am]
BILLING CODE 2210-40-P